Xultophy

insulin degludec and liraglutide · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Xultophy, covering 2015-10-02 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.

See pricing